X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
adult (4) 4
aspirin (4) 4
cardiac & cardiovascular systems (4) 4
cyclooxygenase 2 (4) 4
cyclooxygenase 2 inhibitors (4) 4
double-blind method (4) 4
drug therapy, combination (4) 4
membrane proteins (4) 4
middle aged (4) 4
platelet activation (4) 4
prostacyclin (4) 4
anti-inflammatory agents, non-steroidal - pharmacology (3) 3
aspirin - pharmacology (3) 3
aspirin - therapeutic use (3) 3
cyclooxygenase 1 (3) 3
cyclooxygenase inhibitors - pharmacology (3) 3
female (3) 3
heparin (3) 3
heparin - therapeutic use (3) 3
inhibition (3) 3
isoenzymes - antagonists & inhibitors (3) 3
male (3) 3
metabolites (3) 3
peripheral vascular disease (3) 3
pharmacology & pharmacy (3) 3
platelet aggregation - drug effects (3) 3
platelet aggregation inhibitors - pharmacology (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
thromboxane b2 - blood (3) 3
abciximab (2) 2
administration, oral (2) 2
adverse and side effects (2) 2
aged (2) 2
animals (2) 2
antibodies, monoclonal - therapeutic use (2) 2
aspirin - adverse effects (2) 2
aspirin - antagonists & inhibitors (2) 2
biosynthesis (2) 2
blood platelets - drug effects (2) 2
blood platelets - metabolism (2) 2
cardiovascular diseases - prevention & control (2) 2
cerebrovascular disorders - prevention & control (2) 2
clinical trials (2) 2
cross-over studies (2) 2
cyclooxygenase inhibitors - therapeutic use (2) 2
dose-response relationship, drug (2) 2
drug interactions (2) 2
fibrinolytic agents - adverse effects (2) 2
fibrinolytic agents - therapeutic use (2) 2
ibuprofen - pharmacology (2) 2
immunoglobulin fab fragments - therapeutic use (2) 2
ischemic attack, transient - drug therapy (2) 2
isoprostanes (2) 2
low-dose aspirin (2) 2
medical research (2) 2
medicine, general & internal (2) 2
myocardial infarction - drug therapy (2) 2
myocardial ischemia - drug therapy (2) 2
platelet aggregation inhibitors - adverse effects (2) 2
prostaglandin-endoperoxide synthases (2) 2
sulfones (2) 2
thrombosis (2) 2
thrombosis - etiology (2) 2
ticlopidine - therapeutic use (2) 2
tissue plasminogen activator - therapeutic use (2) 2
treatment outcome (2) 2
6-ketoprostaglandin f1 alpha - analogs & derivatives (1) 1
6-ketoprostaglandin f1 alpha - blood (1) 1
absorption (1) 1
acetaminophen - pharmacology (1) 1
acid (1) 1
acute myocardial-infarction (1) 1
adjunctive therapy (1) 1
advanced glycosylation (1) 1
aged, 80 and over (1) 1
aggregation (1) 1
alphabeta (1) 1
analgesics, non-narcotic - pharmacology (1) 1
anti-inflammatory agents, non-steroidal - therapeutic use (1) 1
antibodies, anticardiolipin - blood (1) 1
anticoagulants (1) 1
anticoagulants - adverse effects (1) 1
anticoagulants - pharmacokinetics (1) 1
anticoagulants - therapeutic use (1) 1
antiphospholipid syndrome (1) 1
antiplatelets (1) 1
antithrombins (1) 1
antithrombins - pharmacology (1) 1
antithrombins - therapeutic use (1) 1
arteriosclerosis - etiology (1) 1
artery disease (1) 1
aspirin - administration & dosage (1) 1
aspirin - pharmacokinetics (1) 1
atherogenesis (1) 1
binding sites (1) 1
bleeding time (1) 1
blood glucose - metabolism (1) 1
caprylates - pharmacology (1) 1
cardiovascular disease (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2001, Volume 345, Issue 25, pp. 1809 - 1817
Journal Article
Journal Article
Blood, ISSN 0006-4971, 05/2001, Volume 97, Issue 10, pp. 3093 - 3099
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 02/2001, Volume 110, Issue 3A, p. S28
  Cyclooxygenase (COZ)-1 and COX-2 catalyze the formajtion of prothrombotic and antithrombotic eicosanoids, respectively. Aspirin, conventional nonsteroidal... 
Prescription drugs | Aspirin | Clinical trials
Journal Article
The American Journal of Cardiology, ISSN 0002-9149, 08/2001, Volume 88, Issue 3, p. 236
  Dose-finding studies and trials of interaction of oral glycoprotein antagonists with other antiplatelet agents have been limited. Kapoor et al hypothesized... 
Medical research | Coronary vessels | Clinical trials | Cardiovascular disease
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2002, Volume 346, Issue 20, pp. 1589 - 1590
To the Editor: The article by Catella-Lawson et al. (Dec. 20 issue) 1 is interesting, particularly in view of the number of patients with cardiac conditions... 
MEDICINE, GENERAL & INTERNAL | Ibuprofen - pharmacology | Humans | Half-Life | Platelet Aggregation Inhibitors - pharmacology | Aspirin - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Aspirin - antagonists & inhibitors | Cyclooxygenase Inhibitors - pharmacology
Journal Article
Blood, ISSN 0006-4971, 05/2001, Volume 97, Issue 10, pp. 3093 - 3099
Abstract The polymorphism responsible for the PlA2 alloantigen on the β3-component of β3-containing integrins is reported to be a risk factor for coronary... 
Journal Article
Journal Article
Arthritis & Rheumatism, ISSN 0004-3591, 08/2000, Volume 43, Issue 8, pp. 1891 - 1896
Specific inhibitors of cyclooxygenase 2 (COX‐2) have been approved for the treatment of osteoarthritis and rheumatoid arthritis. Unlike nonsteroidal... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.